Cancer Therapy And The Immune System

Although manipulation of the host immune response in animal tumor models has at times yielded impressive therapeutic results, attempts to extend these results to human cancers generally have been disappointing.

Several proteins that stimulate subsets of lymphocytes involved in various aspects of the immune response are now produced by recombinant DNA techniques. The pharmacology of these "lymphokines" as potential anticancer agents is being investigated. Interleukin (IL) 2, originally described as a T-cell growth factor, induces the production of cytotoxic lymphocytes (lymphokine-activated killer cells, or LAK cells). IL-2 produces remissions in 10 to 20% of patients with melanoma or renal cell carcinoma when infused at high doses either alone or with lymphocytes that were previously harvested from the patient and incubated with IL-2 in vitro.

The ability of certain anticancer agents to suppress both humoral and cellular immunity has been exploited in the field of organ transplantation and in diseases thought to be caused by an abnormal or heightened immune response. In particular, the alkylating agents cy-clophosphamide and chlorambucil have been used in this context, as have several of the antimetabolites, including methotrexate, mercaptopurine, azathioprine,

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment